ITUA20162292A1 - Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi - Google Patents
Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessiInfo
- Publication number
- ITUA20162292A1 ITUA20162292A1 ITUA2016A002292A ITUA20162292A ITUA20162292A1 IT UA20162292 A1 ITUA20162292 A1 IT UA20162292A1 IT UA2016A002292 A ITUA2016A002292 A IT UA2016A002292A IT UA20162292 A ITUA20162292 A IT UA20162292A IT UA20162292 A1 ITUA20162292 A1 IT UA20162292A1
- Authority
- IT
- Italy
- Prior art keywords
- sexes
- tamoxifen
- patients
- treatment
- cystic fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A002292A ITUA20162292A1 (it) | 2016-04-05 | 2016-04-05 | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
CA3018024A CA3018024A1 (en) | 2016-04-05 | 2017-04-03 | Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes |
US16/089,528 US11191738B2 (en) | 2016-04-05 | 2017-04-03 | Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes |
HUE17715154A HUE064521T2 (hu) | 2016-04-05 | 2017-04-03 | Tamoxifen alkalmazása cisztás fibrózis kezelésére nem nõi pácienseknél |
PCT/EP2017/057895 WO2017174529A1 (en) | 2016-04-05 | 2017-04-03 | Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes |
CN201780021545.2A CN109310652A (zh) | 2016-04-05 | 2017-04-03 | 它莫昔芬在治疗两性患者的囊性纤维化中的用途 |
JP2018552700A JP2019510791A (ja) | 2016-04-05 | 2017-04-03 | 両性の患者における嚢胞性線維症の治療のためのタモキシフェンの使用 |
RS20230888A RS64640B1 (sr) | 2016-04-05 | 2017-04-03 | Upotreba tamoksifena za lečenje cistične fibroze kod pacijenata koji nisu žene |
HRP20231197TT HRP20231197T1 (hr) | 2016-04-05 | 2017-04-03 | Uporaba tamoksifena za liječenje cistične fibroze kod pacijenata koji nisu žene |
PL17715154.5T PL3439645T3 (pl) | 2016-04-05 | 2017-04-03 | Stosowanie tamoksyfenu w leczeniu mukowiscydozy u pacjentów płci innej niż żeńska |
EA201891911A EA036682B1 (ru) | 2016-04-05 | 2017-04-03 | Применение тамоксифена для лечения кистозного фиброза у пациентов обоих полов |
ES17715154T ES2951263T3 (es) | 2016-04-05 | 2017-04-03 | Uso de tamoxifeno para el tratamiento de la fibrosis quística en pacientes que no son mujeres |
EP17715154.5A EP3439645B1 (en) | 2016-04-05 | 2017-04-03 | Use of tamoxifen for the treatment of cystic fibrosis in non-female patients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A002292A ITUA20162292A1 (it) | 2016-04-05 | 2016-04-05 | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUA20162292A1 true ITUA20162292A1 (it) | 2017-10-05 |
Family
ID=56551460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUA2016A002292A ITUA20162292A1 (it) | 2016-04-05 | 2016-04-05 | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
Country Status (13)
Country | Link |
---|---|
US (1) | US11191738B2 (it) |
EP (1) | EP3439645B1 (it) |
JP (1) | JP2019510791A (it) |
CN (1) | CN109310652A (it) |
CA (1) | CA3018024A1 (it) |
EA (1) | EA036682B1 (it) |
ES (1) | ES2951263T3 (it) |
HR (1) | HRP20231197T1 (it) |
HU (1) | HUE064521T2 (it) |
IT (1) | ITUA20162292A1 (it) |
PL (1) | PL3439645T3 (it) |
RS (1) | RS64640B1 (it) |
WO (1) | WO2017174529A1 (it) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009105234A2 (en) * | 2008-02-19 | 2009-08-27 | Combinatorx, Incorporated | Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE214269T1 (de) * | 1997-06-27 | 2002-03-15 | Akzo Nobel Nv | Oral anzuwendende flüssige arzneilösung |
WO2012134965A1 (en) | 2011-03-25 | 2012-10-04 | The Trustees Of Columbia University In The City Of New York | Chloride channel and chloride transporter modulators for therapy in smooth muscle diseases |
-
2016
- 2016-04-05 IT ITUA2016A002292A patent/ITUA20162292A1/it unknown
-
2017
- 2017-04-03 EP EP17715154.5A patent/EP3439645B1/en active Active
- 2017-04-03 CN CN201780021545.2A patent/CN109310652A/zh active Pending
- 2017-04-03 WO PCT/EP2017/057895 patent/WO2017174529A1/en active Application Filing
- 2017-04-03 HU HUE17715154A patent/HUE064521T2/hu unknown
- 2017-04-03 HR HRP20231197TT patent/HRP20231197T1/hr unknown
- 2017-04-03 PL PL17715154.5T patent/PL3439645T3/pl unknown
- 2017-04-03 EA EA201891911A patent/EA036682B1/ru unknown
- 2017-04-03 JP JP2018552700A patent/JP2019510791A/ja active Pending
- 2017-04-03 ES ES17715154T patent/ES2951263T3/es active Active
- 2017-04-03 RS RS20230888A patent/RS64640B1/sr unknown
- 2017-04-03 CA CA3018024A patent/CA3018024A1/en active Pending
- 2017-04-03 US US16/089,528 patent/US11191738B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009105234A2 (en) * | 2008-02-19 | 2009-08-27 | Combinatorx, Incorporated | Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
Non-Patent Citations (3)
Title |
---|
ACHIM D. GRUBER ET AL: "Molecular cloning and transmembrane structure of hCLCA2 from human lung, trachea, and mammary gland", AMERICAN JOURNAL OF PHYSIOLOGY - CELL PHYSIOLOGY, 1 June 1999 (1999-06-01), UNITED STATES, pages 1261 - 1270, XP055321637, Retrieved from the Internet <URL:http://ajpcell.physiology.org/content/276/6/C1261.full.pdf> [retrieved on 20161122] * |
HEIDI LEDFORD: "Tamoxifen takes on cystic fibrosis", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 15, no. 1, 1 January 2009 (2009-01-01), pages 28, XP002665513, ISSN: 1078-8956 * |
RAY D COAKLEY ET AL: "17 beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, vol. 118, no. 12, 1 December 2008 (2008-12-01), pages 4025 - 4035, XP002665514, ISSN: 0021-9738, [retrieved on 20081120], DOI: 10.1172/JCI33893 * |
Also Published As
Publication number | Publication date |
---|---|
PL3439645T3 (pl) | 2023-08-21 |
US11191738B2 (en) | 2021-12-07 |
EA201891911A1 (ru) | 2019-04-30 |
US20200297667A1 (en) | 2020-09-24 |
WO2017174529A1 (en) | 2017-10-12 |
EP3439645B1 (en) | 2023-07-05 |
CA3018024A1 (en) | 2017-10-12 |
EA036682B1 (ru) | 2020-12-08 |
HRP20231197T1 (hr) | 2024-01-19 |
CN109310652A (zh) | 2019-02-05 |
RS64640B1 (sr) | 2023-10-31 |
EP3439645C0 (en) | 2023-07-05 |
JP2019510791A (ja) | 2019-04-18 |
ES2951263T3 (es) | 2023-10-19 |
HUE064521T2 (hu) | 2024-03-28 |
EP3439645A1 (en) | 2019-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3706796T3 (da) | Eksosomerer som RNA terapeutikske midler | |
GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
GB201621480D0 (en) | Use of cannabinoids in the treatment of angelman syndrome | |
DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
SMT201600102B (it) | Tritoqualina per l’uso nel trattamento della fibrosi cistica | |
IT201700028184A1 (it) | Composti e composizioni per il trattamento della fibrosi cistica | |
ES2970224T3 (es) | Tinostamustina para su uso en el tratamiento del sarcoma | |
IL249402A0 (en) | Aminoglycosides for the treatment of Rett's syndrome | |
DK3125874T3 (da) | Et terapeutisk middel til anvendelse i behandlingen af infektioner | |
HUE039750T2 (hu) | Hidroxi-buspiron mozgászavarok kezelésére | |
IL246855A0 (en) | Materials for use in the treatment of retinitis | |
SMT201700018B (it) | Uso di sali di tungsteno (vi) per il trattamento della sterilità femminile in mammiferi non diabetici | |
DK3419673T3 (da) | Genterapi til behandling af sygdom i nethindens tapceller | |
IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
HUE050456T2 (hu) | Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra | |
SMT201700072B (it) | Utilizzo del pidotimod per il trattamento della psoriasi | |
HK1252811A1 (zh) | 用於去勢治療相關症狀之治療的化合物 | |
ITRM20130465A1 (it) | Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica. | |
IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
ITUA20162292A1 (it) | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi | |
LT3405197T (lt) | Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui | |
ITUB20169937A1 (it) | Formulazioni farmaceutiche e loro uso per il trattamento della retinite pigmentosa | |
BR112018006201A2 (pt) | composições para higiene bucal e métodos de uso das composições | |
IT201700028127A1 (it) | Composti e composizioni per il trattamento della fibrosi cistica | |
PT3007772T (pt) | Composições para utilização no tratamento de dislipidemia em doença renal crónica |